The Claim
Patients with exogenous thyrotoxicosis due to levothyroxine therapy have a significantly higher body mass index compared to patients with endogenous hyperthyroidism, despite comparable free triiodothyronine levels, indicating that the metabolic consequences of thyroid hormone excess vary by etiology.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People taking levothyroxine medication for thyroid conditions tend to have a higher body mass index than those whose thyroid overproduces hormones naturally, even when their blood levels of active thyroid hormone are similar. This suggests that the source of excess thyroid hormone may influence body weight differently.
See the scientific wording
Body mass index (BMI) is significantly higher in patients with exogenous thyrotoxicosis due to levothyroxine therapy compared to those with endogenous hyperthyroidism, despite similar FT3 levels, suggesting that metabolic effects of thyroid hormone excess differ by etiology.
What the research says
1 studyEven when people have the same amount of thyroid hormone in their blood, those taking too much thyroid medicine (levothyroxine) tend to have higher body weight than people whose thyroid overproduces hormones naturally. This means where the extra hormone comes from matters for how your body uses energy.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.